Separation of R- and S-thalidomide by reversed-phase HPLC with β-cyclodextrin in the mobile phase

Chirality

Volumn 8, Issue 1, 1996, Pages 11-17

  Reepmeyer, John C ^a  

^a Div Drug Anal Food Drug Admin   (United States)

Author keywords

Chiral separation; High performance liquid chromatography; Inclusion complex; Mobile phase additive; Stereoselective analysis; Thalidomide enantiomers; cyclodextrin

Indexed keywords

2 PROPANOL; ACETONITRILE; ALCOHOL; BETA CYCLODEXTRIN; METHANOL; ORGANIC COMPOUND; TERT BUTYL ALCOHOL; THALIDOMIDE;

COMPLEX FORMATION; CONFERENCE PAPER; DRUG ANALYSIS; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; EQUILIBRIUM CONSTANT; PH; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 0029984345     PISSN: 08990042     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-636X(1996)8:1<11::AID-CHIR4>3.0.CO;2-J     Document Type: Article

References (28)

1. Kaitin, K.I. Thalidomide revisited: New clinical uses for an old drug. Pharmaceut Med. 3:203-210, 1988.
2. Barnhill, R.L., McDougall, A.C. Thahdomide: Use and possible mode of action in reactional lepromatous leprosy and in various other conditions. J. Am. Acad. DermatoL 7:317-323, 1982.
3. Koch, H.P. Thalidomide and congeners as anti-inflammatory agents. Prog. Med. Chem. 22:165-242, 1985.
4. Vogelsang, G.B., Taylor, S., Gordon, G., Hess, A.D. Thalidomide, a potent agent for the treatment of graft-versus-host disease. Transplant. Proc. 18:904-906, 1986.
5. Vogelsang, G.B., Hess, A.D., Gordon, G., Santos, G.W. Treatment and prevention of acute graft-versus-host disease with thalidomide in a rat model Transplantation 41:644-647, 1986.
6. Makonkawkeyoon, S., Limson-Pobre, R.N.R., Moreira, A.L., Schauf, V., Kaplan, G. Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U.S.A. 90:5974-5978, 1993.
7. Blaschke, G., Kraft, H.P., Fickentscher, K., Köhler, F. Chromatographic separation of racemic thalidomide and teratogenic activity of its enantiomers. Arzneimittel-forschung 29:1640-1642, 1979.
8. Fabro, S., Smith, R.L., Williams, R.T. Toxicity and teratogenicity of optical isomers of thalidomide. Nature (London) 215:296, 1967.
9. Knoche, B., Blaschke, G. Investigations on the in vitro racemization of thalidomide by high-performance liquid chromatography J. Chromatogr. A 666:235-240, 1994.
10. ∞ production by human leukemia cell HL-60: Implication of optical resolution of thalidomidal effects. Chem. Pharm. Bull. 42:1157-1159, 1994.
11. Eriksson, T., Bjorkman, S., Roth, B., Fyge, A., Höglund, P. Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide. Chirality 7:44-52, 1995.
12. Knoche, B., Btaschke, G. Stereoselectivity of the in vitro metabolism of thalidomide. Chirality 6:221-224, 1994.
13. Blaschke, G., Kraft, H.P., Markgraf, H. Chromatographic resolutions of racemates, X, optical resolution of thalidomide and other glutarimide derivatives. Chem. Ber. 113:2318-2322, 1980.
14. Aboul-Enein, H.Y., Islan, M.R. Direct HPLC separation of thalidomide enantiomers using cellulose tris-4-methylphenyl benzoate chiral stationary phase. J. Liq. Chromatogr. 14:667-673, 1991.
15. Menges, R.A., Armstrong, D.W. Chiral separations using native and functionalized cyclodextrin-bonded stationary phases in high-pressure liquid chromatography. In: Chiral Separations by Liquid Chromatography, Ahuja, S., ed. Washington, DC: American Chemical Society, 1991;67-100.
16. Sybilska, D., Zukowski, J. Cyclodextrin additives. In: Chiral Separations by HPLC, Krstulovic, A.M., ed. Chichester: Ellis Horwood, 1989:147-172.
17. Krenn, M., Gamcsik, M.P., Vogelsang, G.B., Colvin, O.M., Leong, K. W. Improvements in solubility and stability of thalidomide upon complexation with hydroxypropyl-β-cyclodextrin. J. Pharm. Sci. 81:685-689, 1992.
18. Reepmeyer, J.C., Rhodes, M.O., Cox, D.C., Silverton, J.V. Characternation and crystal structure of two polymorphic forms of racemic thalidomide. J. Chem. Soc. Perkin Trans. 2:2063-2067, 1994.
19. Nefkens, G.H.L. Synthesis of phthaloyl ammo-acids under mild conditions. Nature (London) 185:309, 1960.
20. Casini G., Ferappi, M. Preparation of one optical antipode of 2-phthalimidoglutarimide. Farmaco, Ed. Sci. 19:563-565, 1964.
21. Shealy, Y.F., Opliger, C.E., Montgomery, J.A. D- and L-thalidomide. Chem. Ind. (London) 1030-1031, 1965.
22. Shealy, Y.F., Opliger, C.E., Montgomery, J.A. Synthesis of D- and L-thaltdomide and related studies. J. Pharm. Sci 57:757-764, 1968.
23. Uekama, K., Hirayama, F., Nasu, S., Matsuo, N., Irie, T. Determination of the stability constants for inclusion complexes of cyclodextrins with various drug molecules by high performance liquid chromatography. Chem. Pharm. Bull. 26:3477-3484, 1978.
24. Mohseni, R. M., Hurtubise, R.J. Retention characteristics of several compound classes in reversed-phase liquid chromatography with β-cyclodextrin as a mobile phase modifier. J. Chromatogr. 499:395-410, 1990.
25. Zukowski, J., Sybilska, D., Bojarski, J. Application of α- and β-cyclodextrin and heptakis(2,6-Di-O-methyl)-β-cyclodextrin as mobile phase components for the separation of some chiral barbiturates into enantiomers by reversed-phase high-performance liquid chromatography. J. Chromatogr. 364:225-232, 1986.
26. Debowski, J., Sybilska, D., Jurczak. J. β-Cyclodextrin as a chiral component of the mobile phase for separation of mandelic acid into enantiomers in reversed-phase systems of high-performance liquid chromatography. J. Chromatogr. 237:303-306, 1982.
27. Durhan, D.G., Liang, H. Molecular modelling of the inclusion complexes between β-cyclodextrin and (R)/(S)-methylphenobarbitone and its application to HPLC. Chirality 6:239-244, 1994.
28. Street, K.W. Jr. Cyclodextrin cavity polarity and chromatographic implications. J. Liq. Chromatogr. 10:655-662, 1987.